Thermo Fisher saw accelerating revenue growth in pharma/biotech, AI-driven cost efficiencies, and attractive valuations. See ...

Currently exempt from US tariffs, pharmaceutical manufacturers fear steep surcharges, as promised by the US president on ...

THE Court of Appeals has reaffirmed its previous decision favoring the ruling of the Quezon City Regional Trial Court that ...

THE Court of Appeals (CA) has reaffirmed its previous decision favoring the ruling of a Quezon City Regional Trial Court ...

An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...

President Trump pushed his top economic and trade officials into high-speed talks this spring to secure agreements with major ...

Advisers used tough tactics to bring desired trade deals to the president, but key details in many remain unfinished.

The growing healthcare burden posed by hepatocellular carcinoma, the most common subtype of liver cancer, has prompted the ...

Learn about July 2025’s top biotech deals, featuring major collaborations in small molecules, antibodies, and drug delivery.

Arguably the FDA’s most anticipated decision this month is for a subcutaneous induction formulation of Biogen and Eisai’s ...

Children with moderate/more extensive atopic dermatitis treated with ruxolitinib cream achieved significant disease control ...

Sanofi’s shift to immunology, AI-driven R&D, and strong pipeline offset risks from patent cliffs and legal issues. See why ...